Literature DB >> 20202486

Modulation of transcription factor function by O-GlcNAc modification.

Sabire Ozcan1, Sreenath S Andrali, Jamie E L Cantrell.   

Abstract

O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of nuclear and cytoplasmic proteins is important for many cellular processes, and the number of proteins that contain this modification is steadily increasing. This modification is dynamic and reversible, and in some cases competes for phosphorylation of the same residues. O-GlcNAc modification of proteins is regulated by cell cycle, nutrient metabolism, and other extracellular signals. Compared to protein phosphorylation, which is mediated by a large number of kinases, O-GlcNAc modification is catalyzed only by one enzyme called O-linked N-acetylglucosaminyl transferase or OGT. Removal of O-GlcNAc from proteins is catalyzed by the enzyme beta-N-acetylglucosaminidase (O-GlcNAcase or OGA). Altered O-linked GlcNAc modification levels contribute to the establishment of many diseases, such as cancer, diabetes, cardiovascular disease, and neurodegeneration. Many transcription factors have been shown to be modified by O-linked GlcNAc modification, which can influence their transcriptional activity, DNA binding, localization, stability, and interaction with other co-factors. This review focuses on modulation of transcription factor function by O-linked GlcNAc modification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202486      PMCID: PMC2881704          DOI: 10.1016/j.bbagrm.2010.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  159 in total

1.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

2.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.

Authors:  Donna M Lehman; Dong-Jing Fu; Angela B Freeman; Kelly J Hunt; Robin J Leach; Teresa Johnson-Pais; Jeanette Hamlington; Thomas D Dyer; Rector Arya; Hanna Abboud; Harald H H Göring; Ravindranath Duggirala; John Blangero; Robert J Konrad; Michael P Stern
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 3.  Multiple roles of the tumor suppressor p53.

Authors:  Jill Bargonetti; James J Manfredi
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

Review 4.  Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors.

Authors:  Peter F Johnson
Journal:  J Cell Sci       Date:  2005-06-15       Impact factor: 5.285

5.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry.

Authors:  Zihao Wang; Namrata D Udeshi; Meaghan O'Malley; Jeffrey Shabanowitz; Donald F Hunt; Gerald W Hart
Journal:  Mol Cell Proteomics       Date:  2009-08-19       Impact factor: 5.911

7.  O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation.

Authors:  Xi Li; Henrik Molina; Haiyan Huang; You-You Zhang; Mei Liu; Shu-Wen Qian; Chad Slawson; Wagner B Dias; Akhilesh Pandey; Gerald W Hart; M Daniel Lane; Qi-Qun Tang
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

Review 8.  Glucose regulation of insulin gene expression in pancreatic beta-cells.

Authors:  Sreenath S Andrali; Megan L Sampley; Nathan L Vanderford; Sabire Ozcan
Journal:  Biochem J       Date:  2008-10-01       Impact factor: 3.857

9.  Hepatic glucose sensing via the CREB coactivator CRTC2.

Authors:  Renaud Dentin; Susan Hedrick; Jianxin Xie; John Yates; Marc Montminy
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

10.  Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine.

Authors:  G D Holt; C M Snow; A Senior; R S Haltiwanger; L Gerace; G W Hart
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  112 in total

1.  Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response.

Authors:  Jayme Salsman; Madhav Jagannathan; Patrick Paladino; Pak-Kei Chan; Graham Dellaire; Brian Raught; Lori Frappier
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.

Authors:  Seok-Ho Yu; Michael Boyce; Amberlyn M Wands; Michelle R Bond; Carolyn R Bertozzi; Jennifer J Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  O-GlcNAc-ylation in the Nuclear Pore Complex.

Authors:  Andrew Ruba; Weidong Yang
Journal:  Cell Mol Bioeng       Date:  2016-04-26       Impact factor: 2.321

5.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

Review 6.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 7.  Control of Muscle Metabolism by the Mediator Complex.

Authors:  Leonela Amoasii; Eric N Olson; Rhonda Bassel-Duby
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

8.  Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB.

Authors:  Yan Gao; Jingfang Liu; Zhenzhong Bai; Sandy Sink; Chengyu Zhao; Felipe Ramos Lorenzo; Donald A McClain
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

9.  Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.

Authors:  Sungsu Kim; Jason C Maynard; Yo Sasaki; Amy Strickland; Diane L Sherman; Peter J Brophy; Alma L Burlingame; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

10.  GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells.

Authors:  Yi-Tzang Tsai; Yutaka Itokazu; Robert K Yu
Journal:  Neurochem Res       Date:  2015-10-24       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.